CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Intrathecal Dexamethasone for Chronic Pain and Spinal Stenosis: Clinical Effectiveness and Guidelines

Last updated: December 14, 2020
Project Number: RB1535-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of dexamethasone administered intrathecally for the treatment of chronic pain and spinal stenosis?
  2. What are the evidence-based guidelines regarding the use of dexamethasone administered intrathecally for the treatment of chronic pain and spinal stenosis?

Key Message

No clinical evidence or evidence-based guidelines were identified regarding the clinical effectiveness or use of dexamethasone administered intrathecally for the treatment of chronic pain and spinal stenosis.